SCHEMBL5877583

SCHEMBL5877583

Cc1cccc(-c2nc3cc(Cl)ccc3c(=O)n2CC2CCCC(CN)C2)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.53
ABCC1 P33527 1/20 0.43
CYP3A4 P08684 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2D6 P10635 1/20 0.41
HTR2C P28335 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NLRP3 Q96P20 1/20 0.41
KCNH2 Q12809 1/20 0.41
GHSR Q92847 1/20 0.41
AVPR1A P37288 10/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5878103 0.94 EGFR (0.54) EGFRABCC1CYP3A4KDM4ELMNA
SCHEMBL5877973 0.93 CYP2D6 (0.47) EGFRCYP3A4CYP2D6HTR2CKCNH2
SCHEMBL5878123 0.91 EGFR (0.64) EGFRABCC1CYP3A4KMT2AMEN1
SCHEMBL5877585 0.90 EGFR (0.52) EGFRABCC1CYP3A4KMT2AMEN1
SCHEMBL5878215 0.90 EGFR (0.48) EGFRABCC1KMT2AMEN1CYP2D6
SCHEMBL5877136 0.90 EGFR (0.61) EGFRABCC1CYP3A4CYP2D6HTR2C
SCHEMBL5877278 0.88 EGFR (0.52) EGFRABCC1CYP3A4KMT2AMEN1
SCHEMBL5877858 0.88 AVPR1A (0.49) AVPR1A
SCHEMBL5878159 0.87 AVPR1A (0.49) EGFRAVPR1A
SCHEMBL5877811 0.86 ABCC1 (0.46) ABCC1CYP3A4KMT2ACYP2D6HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7060706-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-06-13 US disclosed
EP-1216233-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023364-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed